Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival

Jianfei Tu, Yahui Ding, Xihui Ying, +5

Scientific Reports

Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE

Chunli Kong, Zhongwei Zhao, Weiyue Chen, +11

European Radiology

The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma

Jianfei Tu, Zhongzhi Jia, Xihui Ying, +4

Medicine

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Wei‐Wen Liu, Huihong Xu, Xihui Ying, +5

Medical Science Monitor

Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma<i>in vitro</i>and<i>in vivo</i>

Jingjing Song, Zhongwei Zhao, Xiaoxi Fan, +6

Oncotarget

The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial

Shourui Huang, Ling Li, Jiali Liu, +17

Evidence-based Complementary and Alternative Medicine

Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary hepatocellular carcinoma and cholangiocarcinoma

Yanran Bi, Xihui Ying, Wanbin Chen, +11

Lipids in Health and Disease

High expression of angiogenic factor AGGF1 is an independent prognostic factor for hepatocellular carcinoma

Jianfei Tu, Xihui Ying, Dengke Zhang, +7

Oncotarget

Effectiveness of Combined 131I-chTNT and Radiofrequency Ablation Therapy in Treating Advanced Hepatocellular Carcinoma

Jianfei Tu, Jiansong Ji, Fazong Wu, +4

Cell Biochemistry and Biophysics

HepatologyRadiation TherapyHepatocellular CarcinomaMedicineLiver Cancer +6

&lt;p&gt;&lt;em&gt;FGFR2-BICC1&lt;/em&gt;: A Subtype Of &lt;em&gt;FGFR2&lt;/em&gt; Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib&lt;/p&gt;

Xihui Ying, Jianfei Tu, Wenxian Wang, +3

OncoTargets and Therapy